Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lucid Group | LCID | Jan 6, 2025 | 3.33 | +1.22 |
Lucky Strike Entertainment A | LUCK | Jan 6, 2025 | 10.41 | 0.00 |
Lufax ADR | LU | Jan 6, 2025 | 2.36 | -0.84 |
Lululemon Athletica | LULU | Jan 6, 2025 | 395.31 | +4.53 |
Lulus Fashion Lounge | LVLU | Jan 6, 2025 | 1.07 | -6.14 |
Lumen Technologies | LUMN | Jan 6, 2025 | 5.82 | +2.83 |
Lument Finance Trust | LFT | Jan 6, 2025 | 2.52 | -3.08 |
Lument Finance Trust A Pref | LFT-A | Jan 6, 2025 | 22.75 | +0.43 |
Lumentum | LITE | Jan 6, 2025 | 90.44 | +1.22 |
Luminar Technologies A | LAZR | Jan 6, 2025 | 8.48 | +27.33 |
Luna Innovations | LUNA | Jan 6, 2025 | 2.05 | 0.00 |
Luokung Technology | LKCO | Jan 6, 2025 | 2.27 | +17.01 |
Luxfer | LXFR | Jan 6, 2025 | 13.18 | +0.46 |
LuxUrban Hotels | LUXH | Jan 6, 2025 | 0.88 | -3.72 |
Luxurban Hotels Pref | LUXHP | Jan 6, 2025 | 15.35 | +2.82 |
Lxp Industrial Trust | LXP | Jan 6, 2025 | 8.12 | +0.74 |
LXP Industrial Trust C Pref | LXP-C | Jan 6, 2025 | 48.73 | +0.84 |
Lyell Immunopharma | LYEL | Jan 6, 2025 | 0.68 | -2.85 |
Lyft A | LYFT | Jan 6, 2025 | 14.39 | +0.84 |
LyondellBasell Industries Nv A | LYB | Jan 6, 2025 | 73.86 | +1.50 |
Lyra Therapeutics | LYRA | Jan 6, 2025 | 0.22 | +6.54 |
Lytus Technologies | LYT | Jan 6, 2025 | 0.85 | -1.16 |
M&T Bank | MTB | Jan 6, 2025 | 193.25 | +0.89 |
M&T Bank ADR Prej J | MTB-J | Jan 6, 2025 | 26.81 | -0.33 |
M&T Bank H Pref | MTB-H | Jan 6, 2025 | 24.81 | -0.40 |
M-tron Industries | MPTI | Jan 6, 2025 | 48.91 | -4.57 |
M/I Homes | MHO | Jan 6, 2025 | 130.21 | -1.32 |
M3-Brigade Acquisition V | MBAVU | Jan 6, 2025 | 10.14 | 0.00 |
M3-Brigade Acquisition V | MBAV | Jan 6, 2025 | 10.06 | 0.00 |
MAC Copper | MTAL | Jan 6, 2025 | 10.52 | -0.85 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.